Why is SMS Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with a 1.65% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 8.51% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 95.89%, the company declared Very Positive results in Sep 26
- ROCE(HY) Highest at 13.50%
- OPERATING PROFIT TO INTEREST(Q) Highest at 11.79 times
- DEBT-EQUITY RATIO(HY) Lowest at 0.42 times
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 03-Nov-26 and has generated -7.8% returns since then
- Multiple factors for the stock are Bullish like MACD, KST, DOW and OBV
4
With ROCE of 13.1, it has a Very Expensive valuation with a 4.1 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 66.95%, its profits have risen by 38.6% ; the PEG ratio of the company is 1.2
5
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -2.11% over the previous quarter and collectively hold 1.37% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you hold?
- Overall Portfolio exposure to SMS Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is SMS Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
SMS Pharma.
66.95%
1.28
52.41%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
8.10%
EBIT Growth (5y)
1.65%
EBIT to Interest (avg)
4.01
Debt to EBITDA (avg)
2.99
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.78
Tax Ratio
24.82%
Dividend Payout Ratio
5.13%
Pledged Shares
17.99%
Institutional Holding
1.37%
ROCE (avg)
9.62%
ROE (avg)
8.51%
Valuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
40
Price to Book Value
5.26
EV to EBIT
31.31
EV to EBITDA
24.70
EV to Capital Employed
4.11
EV to Sales
4.88
PEG Ratio
1.21
Dividend Yield
0.08%
ROCE (Latest)
13.11%
ROE (Latest)
13.88%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Movement
24What is working for the Company
ROCE(HY)
Highest at 13.50%
OPERATING PROFIT TO INTEREST(Q)
Highest at 11.79 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.42 times
NET SALES(Q)
Highest at Rs 316.09 cr
PBDIT(Q)
Highest at Rs 67.65 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.40%
PBT LESS OI(Q)
Highest at Rs 51.48 cr.
PAT(Q)
Highest at Rs 39.85 cr.
EPS(Q)
Highest at Rs 4.25
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for SMS Pharma.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 51.48 cr has Grown at 87.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 27.50 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
At Rs 316.09 cr has Grown at 40.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 224.45 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 11.79 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
At Rs 39.85 cr has Grown at 55.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 25.60 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 316.09 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 67.65 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.40%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 51.48 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 39.85 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 4.25
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 0.42 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio